|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
$430,058
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$471,198
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER SCREENING TRIAL, STUDY COORDINATI
|
N01CN025476-069
|
$4,620,174
|
$924,035
|
O'BRIEN, BARBARA
|
WESTAT, INC
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-22
|
$4,612,382
|
$230,619
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-08
|
$3,827,483
|
$765,497
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
2P01CA049605-19
|
$3,353,514
|
$402,422
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
2P01CA043904-16A1
|
$2,922,793
|
$1,461,396
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-25
|
$2,776,839
|
$2,776,839
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Defects in Immunoregulatory Cell Receptors in Patients with Leukemia/Lymphoma
|
Z01 SC 004002
|
$2,581,222
|
$1,290,611
|
Waldmann, Thomas
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025512-096
|
$2,501,456
|
$500,291
|
KVALE, PAUL
|
HENRY FORD HEALTH SYSTEM
|
|
Lymphoma Specialized Program of Research Excellence (SPORE)
|
2P50CA097274-06
|
$2,496,123
|
$624,031
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$24,311
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Pacific Northwest Prostate Cancer SPORE
|
2P50CA097186-06
|
$2,360,341
|
$472,068
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
DF/HCC Renal Cancer SPORE
|
5P50CA101942-05
|
$2,330,598
|
$466,120
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE in Gl Cancer
|
2P50CA095103-06
|
$2,278,307
|
$569,577
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
|
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
|
5P01CA101956-02
|
$2,215,284
|
$443,057
|
JACOB, SAMSON
|
OHIO STATE UNIVERSITY
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-04
|
$2,163,323
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-04
|
$2,158,606
|
$539,652
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Targeted antigen receptor treatment of cancer
|
5P01CA033049-24
|
$2,150,453
|
$2,150,453
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTER
|
N01CN025515-077
|
$2,132,892
|
$426,578
|
YOKOCHI, LANCE
|
PACIFIC HEALTH RESEARCH INSTITUTE
|
|
Epithelial Ovarian Cancer Program Project
|
5P01CA052477-15
|
$2,029,433
|
$405,886
|
SPRIGGS, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
2P01CA023766-29
|
$2,005,952
|
$401,190
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Innate Immunity: Elucidation and Modulation for Cancer Therapy
|
2P01CA095426-06
|
$1,987,279
|
$1,490,459
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Mixed Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-09
|
$1,985,492
|
$397,098
|
Storb, Rainer
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-07
|
$1,941,997
|
$97,100
|
Blasberg, Ronald
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
GVL without GVHD across HLA barriers: Translational Studies
|
5P01CA111519-02
|
$1,884,598
|
$942,299
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$18,711
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
$186,971
|
Wayne, Alan
|
CCR (NCI)
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-20
|
$1,865,350
|
$1,119,210
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$18,606
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025514-072
|
$1,811,411
|
$362,282
|
CRAWFORD, DAVID
|
UNIVERSITY OF COLORADO
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$17,408
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Evaluation of Predictive Signatures of Prostate Cancer
|
5U01CA114810-03
|
$1,701,313
|
$425,328
|
MERCOLA, DAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-23
|
$1,662,201
|
$332,440
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-085
|
$1,656,966
|
$331,393
|
ANDRIOLE, GERALD
|
THE WASHINGTON UNIVERSITY
|
|
Targeted Therapy of B-cell Malignancies
|
5P01CA103985-03
|
$1,603,282
|
$400,821
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Community Clinical Oncology Program
|
5U10CA035431-24
|
$1,502,482
|
$15,025
|
DAKHIL, SHAKER
|
VIA CHRISTI REG MED CTR-ST. FRANCIS CMPS
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025513-084
|
$1,477,597
|
$295,519
|
CHURCH, TIMOTHY
|
REGENTS OF THE UNIVERSITY OF MINNESOTA
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTERS
|
N01CN025522-086
|
$1,461,594
|
$292,319
|
ISAACS, CLAUDINE
|
GEORGETOWN UNIVERSITY
|
|
Molecular Signatures to Improve Diagnosis and Outcome Pr
|
5U01CA114778-03
|
$1,424,442
|
$356,111
|
CHAN, WING
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
The Biological Basis of Breast Density and Cancer Risk
|
5P01CA107584-02
|
$1,369,207
|
$342,302
|
TLSTY, THEA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Engineered HSV for Treatment of Malignant Gliomas
|
5P01CA071933-10
|
$1,284,905
|
$321,226
|
Whitley, Richard
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025511-072
|
$1,235,772
|
$247,154
|
WEISSFELD, JOEL
|
University of Pittsburgh
|
|
MICHIGAN CANCER RESEARCH CONSORTIUM CCOP
|
2U10CA063848-14
|
$1,210,400
|
$12,104
|
STELLA, PHILIP
|
SAINT JOSEPH MERCY HEALTH SYSTEM
|
|
MD Anderson Cancer Center SPORE in Head and Neck Cancer
|
3P50CA097007-05S1
|
$1,150,000
|
$115,000
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
$56,551
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
Great Lakes/New England Clinical Epidemiology/Validation
|
5U01CA086400-08
|
$1,091,808
|
$109,181
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-22
|
$1,067,633
|
$10,676
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-06
|
$1,030,000
|
$10,300
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORAT
|
N01CN025404-034
|
$1,008,581
|
$201,716
|
CHIA, DAVID
|
THE REGENTS OF THE UNIVERSITY OF CALIFOR
|
Total relevant funding to MOAB for this search: $38,044,563
|